China in Global Clinical Development: Why Early Inclusion Matters August 26, 2026Posted inBiotechnology Leading biotechs are rethinking China’s role in global clinical development. Early inclusion can unlock significant value. Post navigation Previous Post Plant Enzymes Enable Efficient Production of N-(Hydroxycinnamoyl)tyramines with In Situ PrecipitationNext PostScn1b/Gsdmd knockdown promotes M2-like macrophages, modulating inflammation and fibrosis in rat ARDS
